A detailed history of Xtx Topco LTD transactions in Rezolute, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 56,375 shares of RZLT stock, worth $241,285. This represents 0.02% of its overall portfolio holdings.

Number of Shares
56,375
Previous 33,671 67.43%
Holding current value
$241,285
Previous $144,000 89.58%
% of portfolio
0.02%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.13 - $5.31 $93,767 - $120,558
22,704 Added 67.43%
56,375 $273,000
Q2 2024

Aug 12, 2024

BUY
$2.29 - $5.79 $51,891 - $131,201
22,660 Added 205.79%
33,671 $144,000
Q1 2024

May 13, 2024

BUY
$0.95 - $2.55 $10,460 - $28,078
11,011 New
11,011 $28,000

Others Institutions Holding RZLT

About Rezolute, Inc.


  • Ticker RZLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,827,600
  • Market Cap $166M
  • Description
  • Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...
More about RZLT
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.